3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Lymphocytic, Chronic, B-Cell
21
Lymphoma, Mantle-Cell
13
Lymphoma, Non-Hodgkin
10
Lymphoma, Large B-Cell, Diffuse
10
Waldenstrom Macroglobulinemia
7
Lymphoma, Follicular
7
Lymphoma, B-Cell, Marginal Zone
5
Lymphoma
5
Neoplasms
4
Leukemia, B-Cell
4
Lymphoma, B-Cell
3
Burkitt Lymphoma
3
Recurrence
2
Leukemia, Prolymphocytic
2
Leukemia, Lymphoid
2
Leukemia, Hairy Cell
2
Leukemia
2
Hematologic Diseases
2
Bronchiolitis Obliterans Syndrome
2
Squamous Cell Carcinoma of Head and Neck
1
Prostatic Neoplasms, Castration-Resistant
1
Primary Central Nervous System Lymphoma (PCNSL)
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Melanoma
1
Lymphoproliferative Disorders
1
Lymphoma, AIDS-Related
1
Lymphatic Diseases
1
Leukemia, Prolymphocytic, B-Cell
1
Interventions
Specimen Handling
51
Carboplatin
49
pembrolizumab
45
Magnetic Resonance Spectroscopy
43
Pemetrexed
39
Cisplatin
34
Paclitaxel
24
durvalumab
23
osimertinib
20
Nivolumab
19
Gemcitabine
19
Radiosurgery
17
Docetaxel
17
atezolizumab
14
Taxes
12
Radiotherapy
12
Immunoglobulin G
12
Disulfides
12
130-nm albumin-bound paclitaxel
12
Etoposide
11
Educational Status
11
Biopsy
11
Radiation
10
Drug Therapy
10
Blood Specimen Collection
10
Platinum
9
Early Intervention, Educational
9
Cetuximab
9
Methods
8
Bevacizumab
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lung Neoplasms
×
ibrutinib
×
90 days
×
Clear all
No trials found.